Effect of Nasal Bi-level Positive Airway Pressure on 29 Chronic Obstructive Pulmonary Disease Patients with Chronic Respiratory Failure
Zhu Hu
Abstract
Zhu Hu
Abstract
Objective: To investigate the effect of nasal bi-level positive airway pressure(BiPAP) on patients with chronic obstructive pulmonary disease(COPD) complicated with chronic respiratory failure.Methods: All 29 COPD patients with chronic respiratory failure were treat with BiPAP.The arterial blood gas were analysed and the parameters of lung ventilation function were measured before BiPAP and 2 and 12 hours after treatment.Results: Before BiPAP treatment,the parameters of arterial blood gas and lung ventilation function were PaCO_(2)(65±15) mmHg,PaO_(2)(45±15) mmHg,pH(7.28±0.10),FVC(1.25±0.20) L,FEV_(1)(0.65±0.08) L,respectively.Two hours after BiPAP,the parameters changed as PaCO_(2)(60±13) mmHg,PaO_(2)(75±15)mmHg,pH(7.30±0.12),FVC(1.28±0.18) L and FEV_(1)(0.80±0.10) L,respectively.And 12 hours after treatment,the parameters are PaCO_(2)(58±12) mmHg,PaO_(2)(80±15)mmHg,pH((7.33)±0.13),FVC(1.33±0.20) L and FEV_(1)(0.85±0.15) L.Both the levels of PaO_(2) and FEV_(1) had significant changes after the use of BiPAP.(Conclusion:) Nasal BiPAP may be considered a good treatment option for patients with COPD complicated with chronic respiratory failure due to its good improvement of PaO_(2) and FEV_(1).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the effect of nasal bi-level positive airway pressure(BiPAP) on patients with chronic obstructive pulmonary disease(COPD) complicated with chronic respiratory failure.Methods: All 29 COPD patients with chronic respiratory failure were treat with BiPAP.The arterial blood gas were analysed and the parameters of lung ventilation function were measured before BiPAP and 2 and 12 hours after treatment.Results: Before BiPAP treatment,the parameters of arterial blood gas and lung ventilation function were PaCO_(2)(65±15) mmHg,PaO_(2)(45±15) mmHg,pH(7.28±0.10),FVC(1.25±0.20) L,FEV_(1)(0.65±0.08) L,respectively.Two hours after BiPAP,the parameters changed as PaCO_(2)(60±13) mmHg,PaO_(2)(75±15)mmHg,pH(7.30±0.12),FVC(1.28±0.18) L and FEV_(1)(0.80±0.10) L,respectively.And 12 hours after treatment,the parameters are PaCO_(2)(58±12) mmHg,PaO_(2)(80±15)mmHg,pH((7.33)±0.13),FVC(1.33±0.20) L and FEV_(1)(0.85±0.15) L.Both the levels of PaO_(2) and FEV_(1) had significant changes after the use of BiPAP.(Conclusion:) Nasal BiPAP may be considered a good treatment option for patients with COPD complicated with chronic respiratory failure due to its good improvement of PaO_(2) and FEV_(1).
Key concepts: Medicine, COPD, Positive airway pressure, Anesthesia, Arterial blood, Ventilation (architecture), Respiratory failure, Respiratory system